#VisualAbstract Glucagon-Like Peptide-1 Receptor Agonists are Protecting in Type 2 Diabetes Mellitus Patients
Click here to read this article in JAMA Internal Medicine. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Tag: diabetes
Biguanides and dipeptidyl peptidase-4 inhibitors use have similar outcomes for diabetic patients
1. Biguanides and dipeptidyl peptidase-4 (DPP-4) inhibitors show no differences in major cardiac or cerebrovascular events, diabetic complications, or death ...
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
#VisualAbstract: Targeting a Systolic Blood Pressure of <120 mmHg Reduces Vascular Events in High-risk Cardiovascular Patients
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Periodontitis in patients with diabetes and its association with diabetes-related complication
1. Periodontitis has a strong association with Type 2 Diabetes and is exacerbated by poor glycemic control. 2. Type 1 ...
Metformin may reduce all-cause mortality in cancer survivors
1. Among US cancer survivors, metformin was associated with a lower risk of cardiometabolic diseases, all-cause mortality, and cardiometabolic mortality. ...
Novo Nordisk: Awiqli is a once-weekly insulin injection for patients with type 2 diabetes
Awiqli led to greater glycated hemoglobin (HbA1c) reduction, superior blood sugar reduction, and time spent within the recommended blood sugar ...
Podiatric care for diabetic patients is associated with reduced risk of major amputation and death
1. For diabetic patients undergoing hemodialysis, receiving foot and ankle care from a podiatrist within 3 months of a new ...
#VisualAbstract: Semaglutide Improves Outcomes in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Click here to to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Beneficial effects found with combined usage of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
1. Compared with using only using a GLP-1 receptor agonist or an SGLT-2 inhibitor, combination therapy with both drug classes ...
